Nordic walking for individuals with cardiovascular disease: A systematic review and meta-analysis of randomized controlled trials

Cugusi, Lucia; Manca, Andrea; Yeo, Tee Joo; Bassareo, Pier Paolo; Mercuro, Giuseppe; Kaski, Juan Carlos

doi:10.1177/2047487317738592

Cited by 46 publications

(40 citation statements)

References 49 publications

(273 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Recent investigations in people with DM and cardiovascular disease have reported beneficial effects following unconventional forms of exercise, such as aquatic-based exercise, Nordic walking, specific gym-fitness activities, Yoga, Pilates, Tai Chi, and dance-based activities. Less common approaches have been shown to induce positive cardiovascular effects, also improving general well-being, social inclusion, and quality of life of the participants [141][142][143][144][145][146][147].…”

Section: Exercise As Therapy For Diabetes Mellitus: Unconventional Anmentioning

confidence: 99%

Diabetic Cardiomyopathy and Ischemic Heart Disease: Prevention and Therapy by Exercise and Conditioning

Crisafulli

Pagliaro

Roberto

et al. 2020

IJMS

Self Cite

View full text Add to dashboard Cite

Metabolic syndrome, diabetes, and ischemic heart disease are among the leading causes of death and disability in Western countries. Diabetic cardiomyopathy is responsible for the most severe signs and symptoms. An important strategy for reducing the incidence of cardiovascular disease is regular exercise. Remote ischemic conditioning has some similarity with exercise and can be induced by short periods of ischemia and reperfusion of a limb, and it can be performed in people who cannot exercise. There is abundant evidence that exercise is beneficial in diabetes and ischemic heart disease, but there is a need to elucidate the specific cardiovascular effects of emerging and unconventional forms of exercise in people with diabetes. In addition, remote ischemic conditioning may be considered among the options to induce beneficial effects in these patients. The characteristics and interactions of diabetes and ischemic heart disease, and the known effects of exercise and remote ischemic conditioning in the presence of metabolic syndrome and diabetes, are analyzed in this brief review.

show abstract

Section: Exercise As Therapy For Diabetes Mellitus: Unconventional Anmentioning

confidence: 99%

Diabetic Cardiomyopathy and Ischemic Heart Disease: Prevention and Therapy by Exercise and Conditioning

Crisafulli

Pagliaro

Roberto

et al. 2020

IJMS

Self Cite

View full text Add to dashboard Cite

show abstract

“…SET improved walking, haemodynamic, and metabolic outcomes in home or clinical settings using treadmills or other calf‐muscle flexing interventions, but not using stretching exercises . Structured exercise programmes generated more improvement in PAD‐related walking and QOL than non‐structured exercise or exercise advice alone, doubling pain‐free and maximum walking distance for both men and women in 3 months with men experiencing greater gains …”

Section: Resultsmentioning

confidence: 99%

“…67 Clinical, patient-centred, and economic benefits of SET were so consistent 68 that in 2017, the United States Centers for Medicare and Medicaid Services issued a decision memorandum to support health insurance coverage for 12 weeks of supervised treadmill exercise for patients with walking impairment due to PAD. 69 SET improved walking, haemodynamic, and metabolic outcomes in home or clinical settings using treadmills or other calf-muscle flexing interventions, 58,70,71 but not using stretching exercises. 49 Structured exercise programmes F I G U R E 2 Number of controlled clinical trials supporting improved patientcentred outcomes for those treated using the indicated intervention(s) for a PADrelated condition.…”

Section: Improved Walking Distance (44 Studies On 2109 Patients)mentioning

confidence: 99%

Peripheral arterial disease: Scoping review of patient‐centred outcomes

Bolton

2019

International Wound Journal

View full text Add to dashboard Cite

Peripheral arterial disease (PAD) impairs patients' quality of life (QOL), walking and ulcer healing, increasing patient pain, costs, and risks of amputation or mortality. A literature appraisal described PAD treatment capacity to improve validated patient-centred outcomes in controlled clinical studies. The PUBMED database was searched from 1 January 1970 to 21 June 2018, for original and derivative controlled clinical trial references addressing MeSH terms for 'ischemia' AND 'leg ulcer'. Non-ischemic ulcer treatment references were excluded. Frequencies of improved (P < .05) outcomes were reported. Eighty-eight studies on 4153 patients were summarized. Walking, pain or QOL improved mainly for interventions administered before PAD became severe. Amputation incidence, pain and ulcer healing were more frequently reported in those with severe PAD. Independent of PAD severity, patients experienced more likely improved walking, QOL, or pain reduction in response to structured walking interventions or those increasing calf muscle activity. Those with more severe PAD were more likely to report amputation reduction, mainly in response to invasive interventions. Those with PAD experienced more consistently improved patient-centred outcomes if they received multidisciplinary PAD management with supervised walking or calf muscle activity, with more likely amputation risk reduced for those with more severe PAD. Key Messages• Peripheral arterial disease (PAD) progresses in severity from impaired walking and quality of life (QOL) through increasing likelihood of pain, ulceration, gangrene, amputation, or death and magnifies clinical, economic, and patient burdens of venous insufficiency or diabetes • improving PAD-related patient-centred outcomes requires consistent early, effective PAD diagnosis and effective treatment to improve lower limb perfusionAbbreviations: ABI, ankle-to-brachial systolic blood pressure index (ratio), optimally performed using handheld Doppler ultrasound; ALU, arterial leg ulcers; CLI, critical limb ischaemia; DAPT, dual antiplatelet therapy, for example, aspirin plus low molecular weight heparin; DFU, diabetic foot ulcers; ER, endovascular revascularisation; HBO, hyperbaric oxygen; IC, intermittent claudication; IPC, intermittent pneumatic compression of the calf muscle; MLU, mixed aetiology leg ulcers complicated with peripheral arterial disease; NMES, neuromuscular electrical stimulation sufficient to cause contraction of the calf muscle; PAD, peripheral arterial disease; PPG, photoplethysmography a technique for measuring venous emptying; QOL, quality of life; RCT, randomised clinical trial; SET, structured exercise therapy supervised by a professional; SOC, standard of care; TcPO 2 , transcutaneous partial pressure of oxygen; VLU, venous leg ulcer.

show abstract

“…The compliance to secondary prevention and exercise training, as well as awareness of revascularisation failure symptoms needing immediate contact with vascular specialists, are important factors of long-term success. [11][12][13][14] Imaging techniques. Because it is non-invasive and widely available, duplex ultrasound (DUS) performed by experienced operators is usually the first-line technique.…”

Section: Patients' Follow-upmentioning

confidence: 99%

Follow-up of patients after revascularisation for peripheral arterial diseases: a consensus document from the European Society of Cardiology Working Group on Aorta and Peripheral Vascular Diseases and the European Society for Vascular Surgery

Venermo

Sprynger

Desormais

et al. 2019

Eur J Prev Cardiolog

View full text Add to dashboard Cite

Peripheral arterial diseases comprise different clinical presentations, from cerebrovascular disease down to lower extremity artery disease, from subclinical to disabling symptoms and events. According to clinical presentation, the patient's general condition, anatomical location and extension of lesions, revascularisation may be needed in addition to best medical treatment. The 2017 European Society of Cardiology guidelines in collaboration with the European Society for Vascular Surgery have addressed the indications for revascularisation. While most cases are amenable to either endovascular or surgical revascularisation, maintaining long-term patency is often challenging. Early and late procedural complications, but also local and remote recurrences frequently lead to revascularisation failure. The rationale for surveillance is to propose the accurate implementation of preventive strategies to avoid other cardiovascular events and disease progression and avoid recurrence of symptoms and the need for redo revascularisation. Combined with vascular history and physical examination, duplex ultrasound scanning is the pivotal imaging technique for identifying revascularisation failures. Other non-invasive examinations (ankle and toe brachial index, computed tomography scan, magnetic resonance imaging) at regular intervals can optimise surveillance in specific settings. Currently, optimal revascularisation surveillance programmes are not well defined and systematic reviews addressing long-term results after revascularisation are lacking. We have systematically reviewed the literature addressing follow-up after revascularisation and we propose this consensus document as a complement to the recent guidelines for optimal surveillance of revascularised patients beyond the perioperative period.

show abstract

Nordic walking for individuals with cardiovascular disease: A systematic review and meta-analysis of randomized controlled trials

Cited by 46 publications

References 49 publications

Diabetic Cardiomyopathy and Ischemic Heart Disease: Prevention and Therapy by Exercise and Conditioning

Diabetic Cardiomyopathy and Ischemic Heart Disease: Prevention and Therapy by Exercise and Conditioning

Peripheral arterial disease: Scoping review of patient‐centred outcomes

Follow-up of patients after revascularisation for peripheral arterial diseases: a consensus document from the European Society of Cardiology Working Group on Aorta and Peripheral Vascular Diseases and the European Society for Vascular Surgery

Contact Info

Product

Resources

About